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1. Introduction 
The kidney proximal tubule is the site of transport 
of amino acids as well as other solutes present in the 
glomerular filtrate. The microvillar membrane that 
lines the tubule is enzymically complex, particularly 
in regard to the number and diversity of the pep- 
tidases it contains (reviewed in [ 1 I). Several of these 
enzymes have been purified and characterized and 
some of them are known to be among the major pro- 
teins of the membrane. Aminopeptidase M (EC 
3.4.1 l.?), dipeptidylpeptidase IV (EC 3.4.21) and 
neutral endopeptidase (EC 3.4.24) together con- 
tribute -17% of the microvillar membrane protein. 
In contrast to these enzymes, the proteins concerned 
with amino acid transport have not yet been charac- 
terized. This is the more surprising since one would 
expect that a major function, such as amino acid 
transport, might be subserved by some of the major 
proteins of the membrane. Indeed, the existence of 
a group of microvillar peptidases, with no obvious 
physiological function, has prompted the speculation 
that they might play some role in amino acid or pep- 
tide transport [2]. 
Microvillar membrane vesicles were first used to 
study transport in [3] and this type of preparation 
is now widely used (reviewed in [4]). The transport 
by kidney microvillar vesicles of proline [5,6], 
alanine [7], cystine, arginine and other dibasic amino 
acids [8,9] have been reported. The uptake of proline 
and alanine is Na’-dependent, manifested by an 
‘overshoot’ of amino acid accumulation, subsiding 
as the Na’ gradient dissipates towards equilibrium. 
This paper shows that the uptake of L-leucine pro- 
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ceeds by a similar process and that it tnay be inhibited 
by several reagents capable ofinteracting with divalent 
metals. 
2. Experimental 
Pig kidneys, generously given by Asda Farmstores 
Ltd., Lofthousegate, W. Yorkshire, were obtained 
within 5 min of death and immediately cooled on ice. 
Phosphoramidon (N-(a-L-rhamnopyranosyloxy- 
hydroxyphosphinyl-L-leucyl-L-tryptophan) [lo] was 
a gift from Professor H. Umezawa. Institute of Micro- 
bial Chemistry, Kamiosaki, Shinagawa-Ku, Tokyo. 
L-[4,5-3H]Leucine (TRK 170), 40-60 Ci/mmol and 
D-[ I-“HIglucose (TRK 385) 3 - 10 Ci/mmol, were from 
the Radiochemical Centre, Amersham, Bucks., 
HP7 OLL. 
Microvillar vesicles were prepared from 20- 30 g 
fresh pig kidney cortex [ 111. The vesicle pellet was 
resuspended in 100 mM mannitol, 20 mM Tris/Hepes 
[4-(2-hydroxyetliyl)-l-piperazine-ethanesulphonic 
acid] (pi-1 7.4) to give 2.5 mg protein/ml. This suspen- 
sion was incubated at 37°C for 30 min with or without 
inhibitors, then kept at 22°C until used. Transport 
of leucine and glucose was studied in an apparatus 
similar to that described in [ 121. Two droplets, 40 ~1 
vesicles (100 ,ug protein) and IO ~1 containing 5 PCi 
L-[3H]leucine (or D-[3H]glucose), 1 mM L-leucine (or 
D-glucose), 0.5 M NaCl, 100 mM mannitol, 20 mM 
Tris/Hepes (pH 7.4), were pipetted separately into a 
6.5 ml polystyrene tube and the two droplets fused 
by starting the shaker at -100 Hz. The reaction was 
terminated by adding 2.5 ml 0.9%’ (w/v) NaCl, 1 mM 
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Tris/Hepes (pH 7.4) at 0°C. The contents were imme- 
diately filtered by suction (250 mm Hg) using a 
0.45 ,um pore cellulose membrane filter (Miliipore 
HAWP, Millipore (UK) Ltd, Abbey Road, London 
NW10 7SP) presoaked in the wash solution, and 
washed with 2 X 2.5 ml of the cold ‘stop’ solution 
containing 200 FM L-leucine (or D-glucose). After 
drying, the filters were agitated in 1 ml 2methoxy- 
ethanol, followed by the addition, 10 min later, of 
10 ml scintillation fluid. Each experiment was done 
with quadruplicate values for each point and most 
experiments were repeated with 2 or 3 different vesi- 
cle preparations. A correction for nonspecific binding 
was made by subtracting zero-time radioactivity. The 
homogenates and vesicle preparations were assayed 
for aminopeptidase M and dipeptidylpeptidase IV by 
the methods in [ 131. Protein was determined by 
A 280 in the presence of 2% (w/v) sodium dodecyl- 
sulphate. The enrichment values were lo-16-fold 
compared with the homogenate. 
3. Results 
At 22°C the transport of L-leucine rose to a peak 
at 3 min, falling to -40% of this value at 10 min and 
reaching an equilibrium value by 60 min. In most 
experiments an interval of 3 min was used, since this 
minimized errors. In the kinetic experiments, however, 
transport at 1 min was measured. This is only an 
approximation of the true initial rate of uptake since 
linearity is probably limited to the first few seconds 
[ 131. In experiments showing a dependence on 
osmolarity, equilibrium values at 60 min were deter- 
mined. The time course over the first 3 min is shown 
in fig. 1. The dependency on a Na’ gradient can also 
be seen: here the vesicles had been preincubated in 
100 mM NaCl (i.e., at the initial gradient concentra- 
tion), but the same effect was achieved by replace- 
ment of NaCl in the substrate droplet with choline 
chloride or by preincubating the vesicles with 5 1.18 
gramicidin/mg protein. When the osmolarity of the 
medium was changed by varying the concentration of 
mannitol from 0.2-0.5 M the plot of L-leucine uptake 
(at 60 mm) against [mannitol]- was linear and extra- 
polated through zero. This result shows that the vesi- 
cles are osmotically active and that the phenomenon 
observed is transport of the amino acid ralher than 
binding to the membrane surface. 
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Fig.1. Time COUISC of L-leucine uptake. Vesicles were prein- 
cubated for 30 min: (o) control vesicles (no additions); (0) 
0.5 nM L-leucyl-L-tryptophan; (A) 0.5 PM phosphoramidon; 
(=) 100 mM NaCl; (0) 100 mM NaCLO.5 PM phosphoramidon. 
3.1. Inhibition of transport by chelating agents 
Figure 2 shows the effects of EDTA, 1 ,l O-phenan- 
throline, dithiothreitol and L-cysteine. All of these 
agents produced marked inhibition of L-leucine trans- 
port. The most effective was 1 ,lO-phenanthroline with 
a Ki value (used here as the concentration giving 50% 
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Fig.2. Inhibition of L-leucine uptake by chelating agents: (0) 
1 ,I 0phenanthroline (Phen); (o) EDTA; (A) dithiothreitol 
(DTT); (6) L-cysteine (Cys). Results are means of 2 or 3 
experiments. 
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inhibition of the gross uptake) of -3 PM. EDTA was 
less inhibitory (Ki -100 PM). Dithiothreitol also 
strongly inhibited (Ki -10 PM), while the monothiol, 
L-cysteine, was rather less effective (Ki -50 PM). 
3.2. Inhibition of transport by phosphoramidon 
Phosphoramidon at 0.5 PM inhibited the transport 
of L-leucine during the time course shown in fig. 1. 
In this experiment the inhibition was -50% and in 
3 1 vesicle preparations this concentration has consis- 
tently inhibited (mean 57.7 t 2.39, control = 100). 
Preincubation of the vesicles with the unsubstituted 
dipeptide, L-leucyl&L-tryptophan, (with or without 
Pi and L-rhamnose) at the same concentration, had no 
effect compared with control vesicles. Nevertheless in 
all experiments with phosphoramidon, L-leucyl&L- 
tryptophan at the same concentration was used as the 
control. The effect of phosphoramidon was only 
manifested on the Na’-dependent component of the 
transport (fig.1). 
The nature of the inhibition is shown in fig.3. In 
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measured over 0.05-l .O mM. The gross uptake values 
shown by the dashed lines (fig.3a) have been corrected 
by subtraction of the Nat-independent component, 
which is linear with increasing concentration. These 
corrected values are plotted as reciprocals in fig.3b. 
The inhibition is non-competitive in type. The K,, 
for L-leucine transport, with an initial gradient of 
100 mM NaCl, is 370 yM in this experiment. The bind- 
ing of phosphoramidon to the membrane was freely 
reversible. This was shown in an experiment in which 
control and phosphoramidon-treated vesicles were 
washed (by suspending in inhibitor-free medium and 
centrifuging) such that the inhibitor would have been 
diluted > lOOO-fold. 
3.3. Glucose transport 
The effects of some of the inhibitors on glucose 
transport differed from those observed with L-leucine. 
In two experiments phosphoramidon (0.5 PM), dithio- 
threitol(30 PM). EDTA (0.3 mM) had no effect. 
However, 1 ,lO-phenanthroline (30 PM) and phlorizin 
(I mM) both inhibited strongly (>95%). 
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Fig.3. Kinetics of phosphoramidon inhibition of L-leucine uptake. Vesicles were preincubatcd with 0.5 PM L-lcucyl-L-tryptophan 
(o,o), 0.5 PM phosphoramidon (A,“) or 100 mM NaCl (m). The dotted line shows the Na-independent uptake, which in (a) has 
been subtracted from the gross uptake values (dashed lines) to reveal the Na-dependent uptake curves (continuous lines (o,L~)) 
which are shown plotted as reciprocals in (b). Results are means of 2 experiments. 
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4. Discussion 
Our results serve to define some of the properties 
of the L-leucine transport system in kidney micro- 
villi. It is difficult to escape the conclusion that the 
transport protein contains a divalent metal ion: each 
of the four compounds, 1 ,lO-phenanthroline, EDTA, 
cysteine and dithiothreitol, is a powerful chelating 
agent; the most potent of which, 1 ,lO-phenanthroline, 
exhibits a high stability constant with Zn’+, a metal 
known to be a constituent of several microvillar pro- 
teins [ 11. The effect of phosphoramidon deserves fur- 
ther explanation. This N-substituted dipeptide was 
first isolated from Streptomyces tanashiensis and 
shown to be a specific inhibitor of thermolysin and 
related proteinases [IO]. Work in this laboratory 
[ 14,151 had characterized neutral endopeptidase as 
a zinc metalloenzyme with properties, including 
specificity, similar to the microbial proteinases. This 
view was further supported by the demonstration that 
phosphoramidon was a potent competitive inhibitor 
(Ki 2 nM) of the microvillar endopeptidase [161. No 
other microvillar peptidase has been shown to be sus- 
ceptible to this inhibitor. The effects at low concen- 
trations of all five inhibitors are not attributable to a 
general effect on membrane transport, as shown by 
the different results for glucose transport (though the 
strong inhibition by 1 ,lO-phenanthroline is worthy of 
further study). 
Our preliminary results may also encourage a 
speculation: that a single protein, hitherto identified 
as an endopeptidase, might mediate leucine transport. 
Both the peptidase and leucine transport are suscep- 
tible to the same group of inhibitors, one of which, 
phosphoramidon, may be regarded as possessing high 
specificity. There are, however, some quantitative 
discrepancies: the endopeptidase was generally less 
sensitive to the chelators though more susceptible to 
phosphoramidon. Moreover, the inhibition by phos- 
phoramidon was noncompetitive for transport but 
competitive for hydrolysis. In addition, although the 
activity of the endopeptidase is partially dependent 
on ionic strength, it showed no specificity for Na’ 
[ 151. A model based on this speculation might postu- 
late separate sites for peptide hydrolysis and amino 
acid transport with another site(s), for cations, exhib- 
iting Na’ specificity for the activation of transport 
though not for hydrolysis. We emphasise that such a 
model is highly speculative: it does, however, provide 
a basis for further experiments. 
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